Home

Articles
Idebenone  - the ultimate anti-aging drug
   
Alzheimer’s disease
Idebenone  versus Tacrine in Patients with Alzheimer’s disease
  Idebenone  efficacy of idebenone in the treatment of Alzheimer’s disease
  Idebenone  Nerve Growth Factor synthesis stimulators in Alzheimer’s disease
  Idebenone  in the treatment of dementia of the Alzheimer type
  Idebenone  cognitive enhancement therapy for Alzheimer’s disease
  Idebenone  protection from beta amyloid-induced oxidative stress
  Idebenone  protection from beta amyloid-induced memory deficits and neurotoxicity
  Idebenone  a study of 2 doses of idebenone in the treatment of Alzheimer’s disease
  Idebenone  a two year study of idebenone treatment for Alzheimer’s disease
  Idebenone  stimulates NGF synthesis in the treatment of Alzheimer’s disease
  Idebenone  animal model study of Nerve Growth Factor and Alzheimer’s disease
   
Leber’s hereditary optic neuropathy (LHON)
Idebenone  does it shorten the time to visual recovery in Leber’s hereditary optic neuropathy?
  Idebenone  improvement in a patient with Leber’s hereditary optic neuropathy (LHON)
   
Friedreich’s ataxia
Idebenone  reduced heart thickness on 6 of 8 Friedreich’s ataxia patients
  Idebenone  is effective at controlling cardiac hypertrophy in Friedreich’s ataxia
  Idebenone  notable cerebellar improvement in early stage Friedreich’s ataxia
  Idebenone  improvement in mitochondrial cardiomyopathy with idebenone
  Idebenone  effect of idebenone on cardiomyopathy in Friedreich’s ataxia
  Idebenone  Friedreich’s ataxia and frataxin
  Idebenone  and reduced cardiac hypertrophy in Friedreich’s ataxia
  Idebenone  heart function is improved by idebenone in Friedreich’s ataxia
  Idebenone  mitochondrial dysfunction in Friedreich’s ataxia
  Idebenone  Frataxin: Its role in iron metabolism and Friedreich’s ataxia
   
MELAS
Idebenone  improves cerebral mitochondrial oxidative metabolism in MELAS
  Idebenone  in young patients with mitochondrial encephalomyopathy (MELAS)
  Idebenone  therapy in Mitochondrial encephalomyopathy (MELAS)
  Idebenone  and Mitochondrial encephalomyopathy (MELAS)
  Idebenone  successful therapy with idebenone in Mitochondrial encephalomyopathy (MELAS)
  Idebenone  long-term treatment with idebenone and riboflavin in a patient with MELAS
   
Misc.
Idebenone  use in age-related cognitive disorders
  Idebenone  protects hippocampal neurons against beta amyloid neurotoxicity
  Idebenone  functions as a potent protective hepatocyte antioxidant
  Idebenone  neuroprotective effects can be attributed to its antioxidant properties
  Idebenone  inhibition of brain mitochondrial swelling
  Idebenone  suppression of cold ischemia/reperfusion injury of liver endothelium
  Idebenone  ability to eliminate a nitroxide radical in the rat
  Idebenone  interaction with respiratory complexes of heart mitochondria
  Idebenone  effect on serotonin release and serotonergic receptors in rats
  Idebenone  protects against damage in organ preservation solutions
  Idebenone  protects against excitotoxic degeneration in cultured cortical neurons
  Idebenone  protects against disorders due to cerebral hypoxia or ischemia
  Idebenone  protects against toxicity induced by low density lipoprotein
  Idebenone  attenuates neuronal degeneration induced by excitotoxins
  Idebenone  augments long-term potentiation in hippocampal slices in the guinea pig
  Idebenone  effects on stroke-prone, hypertensive rats
  Idebenone  effect on cerebral glucose utilization in rats
  Idebenone  effects on acetylcholine levels in the brains of rats with cerebral ischemia
  Idebenone  protective effect of idebenone against hypoxia in mice
  Idebenone  improves learning and memory impairment induced in rats
  Idebenone  effects on neurological deficits in stroke-prone rats
  Idebenone  effects on memory induced impairment in rats
  Idebenone  effects on cerebral blood flow in rats with cerebral ischemia
  Idebenone  effects on ethanol-induced neurological disorders
  Idebenone  inhibition of brain mitochondrial swelling
  Idebenone  inhibition of platelet aggregation
  Idebenone  effects on monoamine metabolites of patients with dementia
  Idebenone  effects on metabolism of monoamines and cyclic AMP formation in rats
  Idebenone  effects on impairment of radial maze learning in cerebral embolized rats
  Idebenone  effect on lipid peroxidation in rat brain homogenate
  Idebenone  effects on muricidal behavior in rats with raphe lesions
  Idebenone  inhibitory effect on vascular lesions in hypertensive rats